Skip to content
value.today

Rani Therapeutics, LLC

🇺🇸 San Jose, California, USAHealth CareFounded 2012
Total raised
$112 M
4 rounds on record
Latest round
$50 M
Oct 2020
First round on record
May 2015
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Rani Therapeutics, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2020$50 MNo. 4$50 to $250 million

Rani Therapeutics, LLC: Raise no. 4, Oct 2020

Investors in this round

2 investors had bought by the notice of Nov 16, 2020: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$50 M of $75 M offered; $25 M still to sell
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Mir Hashim · Executive Officer, Director
  • Mir Imran · Executive Officer, Director
  • Svai Sanford · Executive Officer
  • Andrew Farquharson · Director
  • Dennis Ausiello · Director
  • Maulik Nanavaty · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mir Imran, President. Source: SEC Form D, newest notice filed Nov 16, 2020. Read the notice at the SEC.

equity, optionsSEC
Aug 2017$39 MNo. 3$10 to $50 million

Rani Therapeutics, LLC: Raise no. 3, Aug 2017

Investors in this round

12 investors had bought by the notice of Sep 13, 2017: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$39 M of $126 M offered; $88 M still to sell
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$172,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Mir Hashim · Executive Officer, Director
  • Mir Imran · Executive Officer, Director
  • Andrew Farquharson · Director
  • David Pyott · Director
  • Maulik Nanavaty · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Joseph Gunnar & Co. LLC (CRD 24795) · New York, New YorkSold in NY

Signed by Mir Imran, President. Source: SEC Form D, newest notice filed Sep 13, 2017. Read the notice at the SEC.

equity, optionsSEC
May 2015$8 MNo. 2$2 to $10 million

Rani Therapeutics, LLC: Raise no. 2, May 2015

Investors in this round

2 investors had bought by the notice of Jun 4, 2015: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $15 M offered; $7 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$320,001
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Mir Hashim · Executive Officer, Director
  • Mir Imran · Executive Officer, Director
  • Andrew Farquharson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Joseph Gunnar & Co. LLC (CRD 24795) · New York, New YorkSold in NY

Signed by Mir Imran, President. Source: SEC Form D, newest notice filed Jun 4, 2015. Read the notice at the SEC.

equitySEC
May 2015$15 MNo. 1$10 to $50 million

Rani Therapeutics, LLC: Raise no. 1, May 2015

Investors in this round

10 investors had bought by the notice of Jun 4, 2015: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $52 M offered; $37 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Mir Hashim · Executive Officer, Director
  • Mir Imran · Executive Officer, Director
  • Andrew Farquharson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mir Imran, President. Source: SEC Form D, newest notice filed Jun 4, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Rani Therapeutics, LLC chose not to state its revenue in its newest notice of a funding round (Nov 2020).

    SEC Form D · Nov 2020

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Nov 2020

That is all the official record says: Rani Therapeutics, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Rani Therapeutics, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 12 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Rani Therapeutics, LLC
NameRoleNamed in
Mir HashimExecutive officerNov 2020
Mir ImranExecutive officerNov 2020
Svai SanfordExecutive officerNov 2020
Andrew FarquharsonDirectorNov 2020
Dennis AusielloDirectorNov 2020
Maulik NanavatyDirectorNov 2020
Mir HashimDirectorNov 2020
Mir ImranDirectorNov 2020
David PyottDirectorSep 2017